Skip to main content
ArticleOPEN ACCESS

Role of structural MRI in Alzheimer's disease

Alzheimer's Research and Therapy
DOI: 10.1186/alzrt47
128Citations
Citations of this article
289Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Atrophy measured on structural magnetic resonance imaging (sMRI) is a powerful biomarker of the stage and intensity of the neurodegenerative aspect of Alzheimer's disease (AD) pathology. In this review, we will discuss the role of sMRI as an AD biomarker by summarizing (a) the most commonly used methods to extract information from sMRI images, (b) the different roles in which sMRI can be used as an AD biomarker, and (c) comparisons of sMRI with other major AD biomarkers. © 2010 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Vemuri, P., & Jack, C. R. (2010). Role of structural MRI in Alzheimer’s disease. Alzheimer’s Research and Therapy. https://doi.org/10.1186/alzrt47

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free